Cas:43024-61-9 buttpark 199-05 manufacturer & supplier

We serve Chemical Name:buttpark 199-05 CAS:43024-61-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

buttpark 19�9-05

Chemical Name:buttpark 199-05
CAS.NO:43024-61-9
Synonyms:buttpark 199-05
Molecular Formula:C9H9N3O3
Molecular Weight:207.18600
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.47 g/cm3
Index of Refraction:
PSA:76.72000
Exact Mass:207.06400
LogP:0.61160

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like buttpark 199-05 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,buttpark 199-05 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,buttpark 199-05 Use and application,buttpark 199-05 technical grade,usp/ep/jp grade.


Related News: China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%. buttpark 199-05 manufacturer China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%. buttpark 199-05 supplier The FDA said its decision allows for the J&J doses to be used in the United States or exported. T buttpark 199-05 vendor The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG��s pharmaceutical business within the Corden Pharma platform. The companies�� goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed. buttpark 199-05 factory China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%.